Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Intervention Indication Therapeutic Area Year Actions
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra) Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2024 View  |  Download
Brentuximab vedotin with chemotherapy (BrECADD) for previously untreated advanced classical Hodgkin lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Chemotherapy Hodgkin lymphoma Haematological Cancer and Lymphomas 2024 View  |  Download
Brentuximab vedotin in addition to cyclophosphamide, doxorubicin, and prednisolone (CHP) for CD30+ mature T-cell lymphoma Brentuximab vedotin (Adcetris; SGN-35) , CHP Mature T-cell lymphoma Haematological Cancer and Lymphomas 2018 View  |  Download
Brentuximab vedotin (Adcetris) for treatment naive Hodgkin’s Lymphoma Adriamycin , Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2017 View  |  Download
Brensocatib for people aged 12 and over with non-cystic fibrosis bronchiectasis Brensocatib (AZD-7986) Bronchiectasis Respiratory System 2024 View  |  Download
BPX‐501 to improve Immune Recovery and Graft versus Host Disease (GvHD) after Haploidentical Stem Cell Transplant Rivogenlecleucel (BPX-501) Graft versus host disease (GvHD) , Immunodeficiency Immunology 2018 View  |  Download
Botulinum toxin type A for preventing episodic migraine Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Migraine Neurology 2023 View  |  Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa Botaretigene sparoparvovec Retinitis pigmentosa Ophthalmology 2023 View  |  Download
Bosutinib (Bosulif) for Philadelphia positive chronic myeloid leukaemia – first line Bosutinib (Bosulif; PF-05208763; bosutinib monohydrate) Chronic myeloid leukaemia (CML) Haematological Cancer and Lymphomas 2017 View  |  Download
BMS-986165 for moderate to severe plaque psoriasis Deucravacitinib (BMS-986165) Plaque psoriasis Dermatology 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications